The global spine biologics market is anticipated to grow through 2023, according to a Transparency Market Research report.
Biologics
A new International Journal of Nanomedicine paper compared 3-D-printed PEKK structures with conventional PEEK surfaces for orthopedics.
The FDA cleared SeaSpine's OsteoBallast Demineralized Bone Matrix in Resorbable Mesh.
MD Stem Cells revealed initial results from its study on paraplegia.
The FDA released its regenerative medicine policy guidelines Nov. 16.
Advertisement
While Health Canada's regulatory system has not proven stem cell procedures, patients continue to seek out private clinics to have the experimental treatments performed, according to CDC News.
National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Numerate a grant.
Here are 65-plus spine surgeons who are participating in clinical trials or have a research focus on biologics and/or stem cells for spine surgery.
The global stem cells market is slated to hit $270.5 billion by 2025, according to a Transparency Market Research report.
Global Stem Cells Groups teamed up with Aesthetic Polyclinic.